NEW YORK, March 23, 2017 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against The Southern Company (“Southern Company” or the “Company”) (NYSE:SO) and certain of its officers, on behalf of shareholders who purchased Southern Company securities between April 25, 2012 and October 29, 2013, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/soc.
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and failed to disclose adverse information about the progress of the Kemper Plant, reassuring investors that the project would be completed by the critical May 2014 deadline, even after cost overruns and other delays began to materialize. Once the true details were made known to the investing public, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/soc or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Southern Company you have until March 24, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | [email protected]


Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move
Anthropic Launches HIPAA-Compliant Healthcare Tools for Claude AI Amid Growing Competition
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites
Trump Weighs Blocking Exxon Investment as Venezuela Deemed “Uninvestable”
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside
Rio Tinto–Glencore Talks Spark Pressure on BHP as Copper Fuels Mining Mega Deals
BlackRock to Cut Around 250 Jobs as CEO Larry Fink Pushes Strategic Shift
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Allegiant to Acquire Sun Country Airlines in $1.5 Billion Deal to Expand U.S. Leisure Travel Network
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids
HSBC Expands UAE Presence With New Asset Management Business and Onshore Funds
Lynas CEO Amanda Lacaze to Retire After 12 Years as Rare Earths Demand Grows
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling 



